Chemed Corporation ( CHE) - Stock Earnings
CHE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2026Q1 | 66.3 million USD | 657.5 million USD |
| 2026Q2 | 67.7 million USD | 673.3 million USD |
| 2026Q3 | 71.6 million USD | 690.9 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CHE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 272.5 million USD | 2.3 billion USD |
| 2024 | 302.0 million USD | 2.4 billion USD |
| 2025 | 265.2 million USD | 2.5 billion USD |
| 2026 Est. | — | — |
CHE
List: Contenders
Price: $548.22
Dividend Yield: 0.11%
Forward Dividend Yield: 0.51%
Payout Ratio: 10.15%
Dividend Per Share: 2.80 USD
Earnings Per Share: 20.88 USD
P/E Ratio: 25.97
Exchange: NYQ
Sector: Healthcare
Industry: Medical Care Facilities
Country: United States
Volume: 83400
Ebitda: 68.2 millionMarket Capitalization: 7.0 billion
Average Dividend Frequency: 4
Years Paying Dividends: 42
DGR3: 13.13%
DGR5: 10.27%
DGR10: 8.95%
DGR20: 12.55%